"MMJ BioPharma Cultivation is engaged not only in a fight for justice but for the integrity of our legal system. As we stand against the DEA's disregard for Supreme Court directives, we are not merely defending our rights; we are upholding the principle that the DEA should not be above the law, especially not one that regulates medical progress. This isn't just our battle-it's a stand for every American whose life and liberties depend on the fair application of justice." - Duane Boise, CEO of MMJ BioPharma Cultivation
Read MoreOne clinical trial site activated
Patient enrollment expected in April
Trial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of Aspire's sublingual aspirin product
Aspire anticipates releasing initial clinical data from trial at the end of the second quarter
Aspire intends to request "fast track" approval on FDA application for its high-dose aspirin product
Duane Boise CEO of MMJ International Holdings stated, “When private citizens or companies fall short of compliance, the DEA acts swiftly and decisively. The question is, why is there no comparable urgency when the failure comes from within the DEA's own ranks? The agency's silence on this matter is not just a public relations problem—it's a breach of public trust."
Read More
The new shampoo combines natural ingredients and a patented Biomimetic Cuticle Technology in a formula that is scientifically proven to repair damaged hair and make it easier than ever to detangle, smooth and style.
Read More
Black Book's ad hoc survey of 200 healthcare executives reveals real-time disruptions, cost inflation, and stalled innovation as Trump-era tariffs expand across key healthcare imports.
Read More
Gelclair® is the company's third commercialized prescription product
Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force
Napo's core target patient audiences for Gelclair are head and neck cancer patients and bone marrow transplant patients
Read MoreTransaction Expected to Help TRNR Generate More than $65M in 2025 Revenue on a Pro Forma basis
Wattbike is the Leading, Indoor-Bike Brand for Elite-Athlete Training and is Used by Olympians and Professional Sports Teams Worldwide - Including the NFL, NBA, MLB, NHL and Premier League
TRNR Listing, Global Distribution Network to Help Wattbike Accelerate Growth, Especially in Key Markets Like US and Germany; Wattbike's Deep Penetration into Leading UK Gyms and Expanding D2C Customer Base to Similarly Speed Up Step-Changes to TRNR Top and Bottom Lines
Transaction Delivers on Previously-Announced LOI, Combines Highly Complementary Businesses to Create a Scaled, International Operation Anchored in the US, Germany and UK, the #1, #2 and #3 Fitness Markets Globally
Deal - Expected to be TRNR's 3rd Within a Year-and-a-Half - Builds on its Transformative Portfolio Strategy for Creating Long-Term Shareholder Value
Acquisition Expected to Close as Early as the Second Quarter of 2025, Subject to Standard Regulatory Requirements
Read MoreCentral to the probe are DEA's Thomas Prevoznik, DEA's Matthew Strait and DEA attorney Aarathi Haig within the DEA's Diversion Control Division, whose conduct has raised serious questions about the integrity of the DEA's regulatory processes.
Read More
During April, the top-rated multi-state podiatry practices emphasizes daily hygiene, exercise, preventive care and early intervention to resolve minor foot issues before they can become major health problems.
Read More"This isn't just about paperwork - it's about a pattern of disregard for the law," said Duane Boise CEO MMJ International Holdings. "The DEA can't demand compliance from others while ignoring its own obligations."
Aarathi D. Haig, a DEA attorney central to the agency's controversial handling of MMJ Biopharma Cultivation's Bulk Manufacturers cannabis research application, is not in good standing with the New Jersey Bar. A February 2023 letter from the New Jersey Board of Bar Examiners states Haig is ineligible for a Certificate of Good Standing
Read MoreSea's pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system)
Sea's lead molecule SPM-0404 is a potential new oral treatment in investigational new drug (IND)-enabling studies for constant bothersome tinnitus, epilepsy, and sporadic ALS (S-ALS)
Pre-clinical development work by Inotiv, Inc. to support Sea filing IND application at FDA
Inotiv Inc will assist Sea to quantify SPM-0404 levels in Clinical Phase 1 and Ph.1b Trials
Exclusive documents obtained reveal DEA Attorney Aarathi Haig, the key DEA attorney in MMJ's cannabis research constitutional Administrative Law Judge case, is ineligible for a Certificate of Good Standing in the N.J. Bar due to compliance failures.
Read More
